Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2011. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on October 11, 2011, involving the purchase of Ordinary shares at a price of 1388.09 pence per share through the Company's Share Reward Plan. No material changes to the company's overall financial position or operations are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly reports a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: October 11, 2011.
- Share Price: 1388.09 pence per Ordinary share.
- Connected Person: Mrs K Thomson (connected to Director Mr P C Thomson).
- Transaction Details: Acquisition of 2 Ordinary shares via personal contribution and 2 Ordinary shares via company matching contribution under the Share Reward Plan.
- Notification Date: October 12, 2011.